VERU INC. Stock Issued During Period, Shares, New Issues
VERU INC. (VERU) had Stock Issued During Period, Shares, New Issues of 7.42 million shares as of 2021-02-22, per its 10-K filed 2022-12-05.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2022-12-05
- 2021-02-22: Stock Issued During Period, Shares, New Issues 7.42M shares.
- 2018-10-01: Stock Issued During Period, Shares, New Issues 7.14M shares.
| Period end | Stock Issued During Period, Shares, New Issues |
|---|---|
| 2021-02-22 | 7.42M shares 10-K · filed 2022-12-05 |
| 2018-10-01 | 7.14M shares 10-K · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |